Emmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation

Reuters
06 May
Emmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation

Emmaus Life Sciences Inc. announced a change in its certifying accountants following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As a result, Marcum resigned as the independent registered public accounting firm for Emmaus on May 2, 2025. The company's Audit Committee approved the engagement of CBIZ CPAs as the new independent registered public accounting firm. The audit report by Marcum for the fiscal year ended December 31, 2024, did not contain any adverse opinions or disagreements, but it did note substantial doubt about Emmaus's ability to continue as a going concern. Emmaus confirmed that no consultations regarding accounting principles or audit opinions were held with CBIZ CPAs prior to this engagement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emmaus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-039783), on May 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10